chrisvoncsefalvay/vaers-outcomes huggingface dataset:
20 weeks pregnant when vaccine was given.  5 hours after vaccine was given the patient complained of numbness and tingling on the left side of her face. Within days the numbness and tingling radiated down her left side. No facial drooping noted. Went to the Emergency Room on 4/11/21.
I contracted COVID-19 approximately 3 months after my 4th dose vaccination and had the following symptoms: Fatigue, Sore Throat, Drippy nose.  I called my Doctor and was prescribed with Paxlovid for 5 days. So far, it did help with my symptoms and as of 07/15/2022 I feel so much better but still feeling a little bit tired,
No additional AE; a temperature excursion for PROQUAD that reports doses were administered following the excursion; Information has been received from a physician regarding a 12-months patient of unknown gender. The patient's medical history, drug allergies, previously drug reactions, concurrent conditions and concomitant medications were not reported.  On 28-DEC-2020, the patient was vaccinated with an improperly stored dose of measles, mumps, rubella and varicella (oka-merck) virus vaccine live recombinant human albumin (rHA) (PROQUAD)0.5 ml injection, for prophylaxis, lot number T021642 with expiration date in 21-DEC-2021 (route of administration, strength and anatomical location not reported).  The measles, mumps, rubella and varicella (oka-merck) virus vaccine live (PROQUAD) was stored at a maximum temperature of 16.2 degrees Fahrenheit (°F) for the time frame of 2 hours and 28 minutes. There was no previous temperature excursion and the call was because of a data logger.   No adverse effects reported.
Mouth sores - three of them on tip of tongue I took a pic if you want it. They don?t hurt much just wanted to let you know because I did not see this listed. Still there as of today 3-13-2021. Also sore arm and some tiredness
pt recvd vax 9MAY94 & w/in 1 hr crying x 24 hrs (no prolonged crying spells of 2-3 hrs or more;  t103; sx lasted x 24 hrs; no swelling around inject site;
Alzheimer's diease from 40 year's of flu vaccines; Initial information received on 06-Jan-2021 regarding an unsolicited valid serious case received from a consumer/non-healthcare professional .  This case involves Adult female patient (unspecified age) who had alzheimer's diease from 40 year's of flu vaccines (dementia allzheimer's type), while she received vaccine INFLUENZA VACCINE.  The medical treatment(s), vaccination(s) and family history were not provided. The patient had no medication details and reason for taking the medicine, medical history, concomitant disease or risk factor.   On an unknown date, the patient received a dose of suspect INFLUENZA VACCINE produced by unknown manufacturer (lot number and expiry date not reported) via unknown route in unknown administration site for prophylactic vaccination.  On an unknown date, the patient developed a serious alzheimer's diease from 40 year's of flu vaccines (dementia alzheimer's type) unknown latency following the administration of INFLUENZA VACCINE. This event was assessed as medically significant.  There were no lab data and results available.  It was not reported if the patient received a corrective treatment.  At the time of reporting, the outcome of event was not recovered.  Information on lot number was requested for this case.; Sender's Comments: This case concerns a female patient (unspecified age) who had dementia alzheimer's type after vaccination with INFLUENZA VACCINEs over 40 years. The time to onset is unknown. The patient had no reported medical history, concomitant disease or risk factor at the time of vaccination. There were no lab data/results available excluding other predisposing etiologies for complete assessment of the case. Based upon the reported information, the role of the suspect vaccinations cannot be assessed.
welty rash appeared Friday night. very uncomfortable and itchy, clothing swapped, was gone by morning.  Later in the morning, reappeared, mainly on back of thighs and rear end. took 2 tablets of 25mg Benadryl. took a n ap, and rash is gone again.
Pt had Pfizer primary series and Moderna Booster Pt reported respiratory distress, hyperventilation, anxiety, flushing/sweating, low fever 99.9F Vitals: 136/88, 98, 22 Pt continues to present as anxious and denies all questions pertaining to relavant hx. Pt denies new medications but admits to not eating "fasting".  Pt admits to panic attack "years ago... but never like this".  Pt continues to hyperventilate w/ continued encouragement from staff.  Pt taken to ED @16:55.  In ED: Vitals: 132/87, 82, 16, 98.2F, 98% Pt diagnosed w/ chest heaviness.  Pt recovered and discharged @19:12.
After receiving Second injection Patient experienced syncope/lightheadedness. Patient stated he hadn't eaten that morning. Patient also stated he Worked out the previous night and had not had much water. Patient given water and crackers and felt better after 30 min of observation.
SHORTNESS OF BREATH,  TROUBLE BREATHING, CATATONIC STATE, POTENTIAL SEIZURE
Doctor called authorities, was told to report due to patient being 17 years old.  Vaccine licensed for greater than 18 years old.  Called patient, patient doing ok.  No adverse event noted.
Chest pain about once/day beginning on either 3/11/03 or 3/18/03.  First occurrence lasted about 5 minutes.  Sometimes pain radiates to L shoulder or occurs only in upper L arm or L shoulder.  Is now on nitroglycerin which relieves pain.
Moderna COVID-19 Vaccine EUA Severe pain at injection site as well as puffiness. Headache Fever Chills Severe Body Aches These side effects  lasted until @ the afternoon of 04/11/21. Itching at  the injection site and a rash is still present at this time.
This is a spontaneous report from a Pfizer-sponsored program Unbranded social media Pilot. A contactable consumer reported for a female patient of an unspecified age and race (Mother) that received  pneumococcal 13-val conj vac (dipht crm197 protein) on unknown date at single dose for immunization. The patient has had pneumonia twice, and almost died from it once and that was after getting the pneumococcal vaccine. The outcome of the event was unknown.  No follow-up attempts are possible. No further information is expected. Pfizer is Marketing Authorization Holder of pneumococcal 13-val conj vac (dipht crm197 protein) in the reporter's country. This may be a duplicate report in situations where another Marketing Authorization Holder of pneumococcal 13-val conj vac (dipht crm197 protein) has submitted the same report to the regulatory authorities.
Palpitations; Felt overwhelmed, had to lay down; Racing heart rate; 88 days since first dose was administered on 22Jan2021 patient never went for 2nd dose.; This spontaneous case was reported by a consumer and describes the occurrence of PALPITATIONS (Palpitations), FEELING ABNORMAL (Felt overwhelmed, had to lay down), HEART RATE INCREASED (Racing heart rate) and PRODUCT DOSE OMISSION ISSUE (88 days since first dose was administered on 22Jan2021 patient never went for 2nd dose.) in an 83-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. C42L20A) for COVID-19 vaccination.     No Medical History information was reported.    On 22-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 22-Jan-2021, the patient experienced PALPITATIONS (Palpitations), FEELING ABNORMAL (Felt overwhelmed, had to lay down), HEART RATE INCREASED (Racing heart rate) and PRODUCT DOSE OMISSION ISSUE (88 days since first dose was administered on 22Jan2021 patient never went for 2nd dose.). At the time of the report, PALPITATIONS (Palpitations) and HEART RATE INCREASED (Racing heart rate) had resolved and FEELING ABNORMAL (Felt overwhelmed, had to lay down) and PRODUCT DOSE OMISSION ISSUE (88 days since first dose was administered on 22Jan2021 patient never went for 2nd dose.) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 22-Jan-2021, Heart rate: racing (High) Heart rate increased..     mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was withdrawn on an unknown date.       No concomitant medicines were reported. No treatment information were reported.
Menstrual issues.  I was finishing my current cycle and immediately after the first shot I starting bleeding VERY heavy again for a number of days.  I received the 2nd dose on 5/19/21 and my cycle after that was delayed 2 weeks past my normal due date.  Then I bled heavy for 16 days.  That has never happened before.  It took 5 months for my cycle to return to normal.
About 4 hours from getting my shot, I looked at my thighs and there was a window pane red design on both thighs.  It did not itch.  It covered my entire thigh, both left and right.  After I noticed this, I checked back about 10 minutes later and it appeared to be fading.  Within an hour, it was totally gone.
Information has been received from a physician concerning a 2 month old male with no medical history or allergies who on 06-FEB-2004 was vaccinated with an oral dose of Rotateq. There was no concomitant medication. On 07-FEB-2007, within 24 hours of vaccination, the patient developed bloody stools and was hospitalized. The patient's outcome was not reported. There was no product quality complaint involved. Additional information has been requested.
urticaria to bilateral upper extremity (BUE); This is a spontaneous report from a contactable nurse (patient).  A 33-year-old female patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE lot/batch number not provided), via an unspecified route of administration on 19Dec2020 21:00 at SINGLE DOSE for COVID-19 immunization at the hospital.  Medical history included diabetes mellitus (DM), hypertension (HTN), depression, obesity, hyperlipidaemia (HLD), migraines, and degenerative disk disease (IDD).  The patient also had allergies with sulfa, oyesters, and adhesives. Concomitant medication included insulin aspart (NOVOLOG), bupropion hydrochloride (WELLBUTRIN), metformin (METFORMIN), sumatriptan (SUMATRIPTAN), and losartan potassium (LOSAR) for unknown dates and indications. Prior to vaccination, the patient was not diagnosed with COVID-19 and had not been tested for COVID-19 since vaccination. On 19Dec2020 17:00, the patient experienced urticaria to bilateral upper extremity (BUE). The patient did not received any treatment for the event. The patient was recovering from the event.  Information on the Lot/batch number has been requested.
This spontaneous report as received from a pharmacist refers to a newborn male patient of unknown age. On 16-OCT-2012 16:47, the patient was vaccinated with RECOMBIVAX HB that had been exposed to temperatures below 32F for 6 hours. During that 6 hour time period, the vaccine was exposed to 28.8F for 1.5 hours. Administration route was not reported. Two lot # were involved and the lot # were reported as: 0294AE, expiry date on 06-SEP-2013; and 0385AE, expiry date on 08-nov-2014. it was unspecified which lot # the patient was administered. the outcome of event was unknown. It was unspecified if the patient sought medical attention. This is one of several reports received from the same source. Additional information has been requested.
Local adverse reaction/cellulitis. Given Keflex, Prednisone and Atanax. Seen in clinic 6/13/03.
Bleeding into the retina of his left eye, obscuring vision Received injection of Avastin into left eye the next day No improvement yet We understand this could easily have been the natural course of his previously diagnosed macular degeneration, it?s just that he hadn?t bled in many years, and never in that eye, and after recently getting covid injection and it being experimental we thought we should report it in case
FLU-LIKE SYMPTOMS (FEVER); This spontaneous report received from a consumer concerned a 71 year old female. The patient's height, and weight were not reported. No past medical history or concurrent conditions were reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: Unknown) dose, start therapy date were not reported for prophylactic vaccination. The batch number was not reported. Per procedure, no follow-up will be requested for this case. No concomitant medications were reported.  On an unspecified date, the patient experienced flu-like symptoms (fever). Laboratory data (dates unspecified) included: Body temperature (NR: not provided) 102. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from flu-like symptoms (fever). This report was non-serious.
PATIENT LOSS CONSCIOUSNESS THEN SEIZED WITH POSTURING FOR APPROX 3 SECONDS. REGAINED CONSCIOUSNESS THEN SEIZED FOR APPROX 3 SECONDS WITH POSTURING. REGAINED CONSCIOUSNESS THEN SEIZED 3RD TIME WITH MORE RIGID POSTURING.
Initial reaction mild, stiffness in left arm, pain and swelling around injection site. Next day woke up with muscle ache and weakness. Migraine-like headache, neckache, nausea. Feeling of disorientation, fever of 102/chills. Took excedrin for symptoms, most faded by 1pm 29 April 2021. Woke up 30 April 2021 with fever 100 degrees, took ibuprofen, fever broke with sweating. Mild itchiness, redness, and swelling persist at injection site.
COVID 19 Treatment; COVID 19 Treatment; This is a spontaneous report received from contactable reporter(s) (Consumer or other non-HCP). The reporter is the patient.  A 61-year-old male patient received BNT162b2 (BNT162B2), on 28Feb2021 at 15:45 as dose 1, single (Lot number: EN6206), in right arm, on 21Mar2021 at 12:00 as dose 2, single (Lot number: EN6208), in left arm and on 05Oct2021 at 10:45 as dose 3 (booster), single (Lot number: 30135BA) at the age of 60 years, in right arm for covid-19 immunisation; coviD-19 vaccine mrna (mrna 1273) (MODERNA COVID-19 VACCINE), on 29Apr2022 at 13:00 as dose 4 (booster), single (Lot number: 056MZIA), in left arm for covid-19 immunisation. The patient's relevant medical history included: "COPD" (unspecified if ongoing); "Type 2 Diabetes" (unspecified if ongoing); "High Cholesterol" (unspecified if ongoing); "Gastroparesis" (unspecified if ongoing); "enlarged prostate" (unspecified if ongoing); "low testosterone" (unspecified if ongoing). Concomitant medication(s) included: METFORMIN, start date: Jan2018; ATORVASTATIN, start date: Jan2018, stop date: 18Jul2022; TESTOSTERONE, start date: Jan2018. The following information was reported: VACCINATION FAILURE (medically significant), COVID-19 (medically significant) all with onset 2022, outcome "not recovered" and all described as "COVID 19 Treatment". The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: (unspecified date) Negative, notes: I tested negative for one day; (unspecified date) Positive, notes: The next day I tested positive; (unspecified date) Positive, notes: Day 2 I also tested positive; (unspecified date) Positive, notes: On day 3 I tested positive; (2022) Positive, notes: Treatment of COVID-19. Therapeutic measures were taken as a result of vaccination failure, covid-19. Received treatment with Paxlovid. Clinical course: The patient tested negative for one day. The next day, he tested positive and felt a little tired. He was positive on day 2 also. On day 3 he tested positive and he woke up with worse symptoms than in the first round of covid. He was exhausted, had sore throat, slight fever, sinus congestion, headache, very sore muscles including his jaw, and the beginning of an acute bronchitis episode which happened often but did not happen with the original covid round.
Suspected cellulitis at site of injection. Symptoms include pain at injection site, swelling, redness, slight fever. TX cephalexin 500mg
Sometime post vax, the pt's developed breakthrough cases of varicella with greater than 50 lesions. No further information is available.
Pt has welps on neck and left arm, stated started about 10 am (11-22-05), received flu vaccine on 11-21-05. Took Bactrim DS on 11/21/05 as well. Advised "stop" Bactrim see physician who ordered. Follow-up Information 14-APR-2006: Prob reaction to Bactrim
generalized hives and pruritis; onset within 10-15 post injection.  Diphenhydramine 25mg administered within 30 minutes of injection.  Patient monitored for 2 hours with symptoms mostly resolving with only slight redness upon discharge.
Five or six pt devel red, swollen lumps @ the inject site; all the parents called to report the rxn & two of the pts were seen in the office;
Arm was sore for a couple of days but it went away. On March 11th, arm began hurting again and I had an approximate 3x2 red rash at the vaccination site that burned and itched. I have been applying hydrocortisone since I became aware of it.
This spontaneous report as received from a pharmacist refers to a patient of unknown age and gender. Information about patient's medical history was not provided. On 15-MAY-2015, the patient was vaccinated with a dose of improperly stored MMR II (therapy type: unknown) (dose, frequency and route of administration were not specified, lot # K020188, expiration date: 22-OCT-2016). Concomitant medications was not reported. No adverse event was reported. No product quality complaintt was involved. Additional information has been requested.
devel high fever 1 hr following inject; had convuls x 15-20mins duration; during that time cyanotic; went to hosp 1 1/2 hr later 7PM-1AM; MD wanted pt to stay over nite;par refused
injection site was very sore; fatigued; Booster; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non-HCP).  A 44-year-old male patient received BNT162B2 ((PFIZER-BIONTECH COVID-19 VACCINE, formulation: Solution for injection) (Batch/Lot number: unknown) as dose number unknown (booster), single for COVID-19 immunisation. The patient relevant medical history and concomitant medications were not reported. Vaccination history included: BNT162B2 (DOSE 1), for COVID-19 Immunization, BNT162B2 (DOSE 2), for COVID-19 Immunization. The following information was reported: VACCINATION SITE PAIN (non-serious), outcome "unknown", described as "injection site was very sore"; FATIGUE (non-serious), outcome "unknown", described as "fatigued"; IMMUNISATION (non-serious), outcome "unknown", described as "Booster".  The lot number for BNT162B2 was not provided and will be requested during follow up.
Initial unsolicited report received from a consumer via social media on 10 Oct 2016. This case is linked with 2016SA188144, 2016SA188556, 2016SA188803, 2016SA188804, 2016SA188805, 2016SA188806, 2016SA188807, 2016SA188808, 2016SA188809, 2016SA188810, 2016SA188811, 2016SA188812, 2016SA188813, 2016SA188814, 2016SA188815, 2016SA188817, 2016SA188818, 2016SA188819, 2016SA188820, 2016SA188821, 2016SA188822, 2016SA188833, 2016SA188834, 2016SA188835, 2016SA188836, 2016SA188837, 2016SA188838, 2016SA188839, 2016SA188840, 2016SA188841, 2016SA188842, 2016SA188843, 2016SA188844, 2016SA188845, 2016SA188846, 2016SA188847, 2016SA188848, 2016SA188849, 2016SA188850, 2016SA188851 (Same reporter source, same vaccine). This case involves a patient (age and gender not reported) who was vaccinated with a dose of INFLUENZA VACCINE (Flu shot) (batch number, expiry date, dose, dose in series, route and site of administration were not reported) on unspecified date. The patient's medical history and concomitant medications were not reported. On an unspecified date, following the vaccination, patient felt worse. The patient's laboratory data and corrective treatment was not reported. The outcome of event was unknown. List of documents held by sender: none.
Patient reported general malaise, itching, and hives across her entire body roughly 20 minutes after the vaccine was administered. gave the patient 50 mg oral diphenhydramine and brought patient to an empty room to lie down. directed one of the facility nurses to call EMT.  administered 0.3 mg epinephrine IM into the right thigh (via autoinjector). EMT arrived roughly 20 minutes later, evaluated patient and administered IV fluids and transported patient to ER for further evaluation.
Information has been received from a physician referring to 14 anonymous patients of unknown age and gender. Patients' concurrent conditions, concomitant medication and medical history were not provided. On unknown dates between 12-APR-2015 and 30-JUN-2015, the 14 patients were vaccinated with expired GARDASIL (lot # H016238, expiry date 11-APR-2015, dose and route were not provided). The physician reported that the GARDASIL had previous temperature excursions on unknown dates and was unable to provide the excursion details at this time. No adverse symptoms were reported. The physician called back on 09-JUL-2015 and provided the names of 14 patients administered improperly stored and expired doses of GARDASIL. Physician did not specify what dose in the GARDASIL series was administered to each patient. One of the patients was administered the vaccine on 21-APR-2015 and 22-JUN-2015. This is one of several reports received from the same reporter. Additional information has been requested.
Swelling Injection Site; Sore Injection Site; Armpit is Sore; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE SWELLING (Swelling Injection Site), VACCINATION SITE PAIN (Sore Injection Site) and AXILLARY PAIN (Armpit is Sore) in a 66-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 28-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 01-Mar-2021, the patient experienced VACCINATION SITE SWELLING (Swelling Injection Site), VACCINATION SITE PAIN (Sore Injection Site) and AXILLARY PAIN (Armpit is Sore). At the time of the report, VACCINATION SITE SWELLING (Swelling Injection Site), VACCINATION SITE PAIN (Sore Injection Site) and AXILLARY PAIN (Armpit is Sore) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No treatment information was provided. No relevant concomitant medications reported.
rash on waist, groin, upper thighs, sides, back. Diagnosed by PA as rosacea on 4/12/21 and 4/22/21. Treated with topical steroids.
Shortness of breath,  I went home and did a breathing treatment followed by using inhaler.
p/vax pt c/o purpura-like rash this AM on rt hand & arm;no rash on rt upper arm or @ inj site-rash onset 10/27/99;
Hospitalized 11/23/2021-still admitted currently; COVID-19 positive 11/23/2021; fully vaccinated plus booster  CHIEF COMPLAINT: COVID  ASSESSMENT / PLAN: Acute Respiratory Failure, secondary to COVID-19 o COVID-19 Infection - confirmed on 11/23/2021.  o Vaccine Status: Fully vaccinated (Pfizer).  Booster: Yes, dose on 11/17/2021 o Outpatient CXR (11/8/2021) suspicious for CAP - treated with Augmentin and Azithromycin o CTA Thorax (11/23/2021) - bilateral ground glass opacities, negative for PE o Abnormal Labs: ? Glucose - 61 § Corrected in ER ? Cr - 1.10 ? WBC - 3.94 o Plan for Admission to Blodgett ? Hold Decadron as patient is not requiring O2. Did desaturate with ambulation but otherwise normal. Start if hypoxia occurs.  ? Hold ABX, secondary to questionable Cdiff. § Procalitonin ordered  ? Not eligible for Remdesivir ? Trend CBC, CMP, D-Dimer, CRP ? Follow stool cultures ? Acapella, mucinex BID and Albuterol BID ? Encourage prone positioning, tessalon perles PRN, albuterol PRN ? Continuous O2 monitoring - not currently on O2.  ? Respiratory Isolation
Patient received influenza vaccination in the morning before work and noticed throughout the day that her arm was feeling more strange than it had to prior influenza vaccines.  When she went home from work, she noticed that her arm was very red, swollen, and warm to the touch.  She took a Benadryl that evening and reported the reaction to us the next day.  She said her arm had improved slightly overnight, but she still went to her work's staff physician who diagnosed her with cellulitis.  The physician did not think it was vaccine related but patient has no other signs of bites, scratches, or cuts at the infection site.